Adding Velcade Increased Overall Survival By 13.3 Months at Five-Year Analysis
Perifosine Increases PFS In Phase II Study
Researchers Identify Nine Cancer Genes-Five Linked to CLL For The First Time
Carfilzomib Demonstrates Clinical Benefit Rate of 64%
Single-Letter Mutation Found Responsible For Waldenstrom’s
New Methods Uncover 1,800 RNAs Linked To Breast Cancer
Gene Expression Analyses Can Guide MDS Treatments
Analysis Reveals Patient Subset With Lower PFS in Phase III Trial
Interim Results Show Vaccine Lowers Breast Cancer Recurrence
CTCs Do Not Affect Survival, But Could Signal Metastases
Childhood Cancer Survivors Do Not Have an Increased Risk Of Passing On Birth Defects
Trials Approved by NCI CTEP For the Month of December
FDA Grants Orphan Designation To Photofrin for Mesothelioma
Trending Stories
- The story of daraxonrasib is the ultimate hero’s journey
A narrative curve with twists, turns, intrigue, drama—and a blow to a mighty foe - As his Senate testimony alleged danger from mRNA COVID vaccine, El-Deiry had an offer to run NCI Frederick lab
The job offer to run the lab—home to virus research, RAS Initiative, and data science—was quickly rescinded - Pancreatic cancer breakthrough came from smart scientists making smart bets—not from politicization of science
- At Senate hearing, Brown’s El-Deiry and other witnesses say they were targeted for arguing that mRNA vaccine may be linked to cancer
- Pancreatic cancer finally starts to budge as daraxonrasib doubles overall survival
- Proposed OMB rule aims at the heart of the U.S. research enterprise—and scientists are fighting back
“The question isn’t whether politics will influence research. Under this proposal, that’s the point. That’s their goal.”
